- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Decibel Therapeutics (NASDAQ:DBTX), Quotes and News Summary
Decibel Therapeutics (NASDAQ: DBTX)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-19 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.550 | -0.560 | -0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Decibel Therapeutics Questions & Answers
You can purchase shares of Decibel Therapeutics (NASDAQ: DBTX) through any online brokerage.
Other companies in Decibel Therapeutics’s space includes: Fortress Biotech (NASDAQ:FBIO), Anixa Biosciences (NASDAQ:ANIX), CytomX Therapeutics (NASDAQ:CTMX), OncoCyte (NASDAQ:OCX) and TCR2 Therapeutics (NASDAQ:TCRR).
The latest price target for Decibel Therapeutics (NASDAQ: DBTX) was reported by Citigroup on Tuesday, May 17, 2022. The analyst firm set a price target for 15.00 expecting DBTX to rise to within 12 months (a possible 237.08% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Decibel Therapeutics (NASDAQ: DBTX) is $4.45 last updated August 5, 2022, 8:00 PM UTC.
There are no upcoming dividends for Decibel Therapeutics.
Decibel Therapeutics’s Q2 earnings are confirmed for Friday, August 19, 2022.
There is no upcoming split for Decibel Therapeutics.
Decibel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.